Advertisement
Screener

Opus Genetics, Inc. (IRD) Graph

2.8 / 5 stars · 68/120 Roast Me

IRD Revenue Flow

IRD Graph summary

Opus Genetics, Inc. (IRD). Quarter ended 2026-06-30. Reported revenue sources, expenses and earnings; undisclosed amounts are not inferred.

How Opus Genetics, Inc. made money in the latest quarterLatest-quarter revenue sources flow through cost of revenue, gross profit, operating expenses, tax, and net income. $0.00B $0.02B$-0.02B$0.01B$-0.02B$0.00B$-0.01B Revenue from contracts with customers, excluding assessed tax$0.00BDeclared revenue$0.00B Operating expenses$0.02BOperating income$-0.02BGeneral and administrative$0.01BPre-tax income$-0.01BIncome tax$0.00BNet income$-0.01B

Similar stocks

Stock NameCountryMarket CapPE Ratio
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Rezolute, Inc. (RZLT)United States$0.382B-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Advertisement